These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9933146)

  • 1. Differences in agonist-independent activity of 5-Ht2A and 5-HT2c receptors revealed by heterologous expression.
    Grotewiel MS; Sanders-Bush E
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Jan; 359(1):21-7. PubMed ID: 9933146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agonist properties of N,N-dimethyltryptamine at serotonin 5-HT2A and 5-HT2C receptors.
    Smith RL; Canton H; Barrett RJ; Sanders-Bush E
    Pharmacol Biochem Behav; 1998 Nov; 61(3):323-30. PubMed ID: 9768567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the R(-) and S(+) isomers of MDA and MDMA on phosphatidyl inositol turnover in cultured cells expressing 5-HT2A or 5-HT2C receptors.
    Nash JF; Roth BL; Brodkin JD; Nichols DE; Gudelsky GA
    Neurosci Lett; 1994 Aug; 177(1-2):111-5. PubMed ID: 7824160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-affinity agonist binding correlates with efficacy (intrinsic activity) at the human serotonin 5-HT2A and 5-HT2C receptors: evidence favoring the ternary complex and two-state models of agonist action.
    Fitzgerald LW; Conklin DS; Krause CM; Marshall AP; Patterson JP; Tran DP; Iyer G; Kostich WA; Largent BL; Hartig PR
    J Neurochem; 1999 May; 72(5):2127-34. PubMed ID: 10217294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activities of novel aryloxyalkylimidazolines on rat 5-HT2A and 5-HT2C receptors.
    Siegel BW; Freedman J; Vaal MJ; Baron BM
    Eur J Pharmacol; 1996 Feb; 296(3):307-18. PubMed ID: 8904083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dihydrobenzofuran analogues of hallucinogens. 4. Mescaline derivatives.
    Monte AP; Waldman SR; Marona-Lewicka D; Wainscott DB; Nelson DL; Sanders-Bush E; Nichols DE
    J Med Chem; 1997 Sep; 40(19):2997-3008. PubMed ID: 9301661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of homogeneous high-affinity agonist binding assays for 5-HT2 receptor subtypes.
    Song J; Hanniford D; Doucette C; Graham E; Poole MF; Ting A; Sherf B; Harrington J; Brunden K; Stricker-Krongrad A
    Assay Drug Dev Technol; 2005 Dec; 3(6):649-59. PubMed ID: 16438660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional characterization of agonists at recombinant human 5-HT2A, 5-HT2B and 5-HT2C receptors in CHO-K1 cells.
    Porter RH; Benwell KR; Lamb H; Malcolm CS; Allen NH; Revell DF; Adams DR; Sheardown MJ
    Br J Pharmacol; 1999 Sep; 128(1):13-20. PubMed ID: 10498829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pleiotropic behavior of 5-HT2A and 5-HT2C receptor agonists.
    Berg KA; Maayani S; Goldfarb J; Clarke WP
    Ann N Y Acad Sci; 1998 Dec; 861():104-10. PubMed ID: 9928246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased basal phosphorylation of the constitutively active serotonin 2C receptor accompanies agonist-mediated desensitization.
    Westphal RS; Backstrom JR; Sanders-Bush E
    Mol Pharmacol; 1995 Aug; 48(2):200-5. PubMed ID: 7651352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in agonist-independent and -dependent 5-hydroxytryptamine2C receptor-mediated cell division.
    Westphal RS; Sanders-Bush E
    Mol Pharmacol; 1996 Mar; 49(3):474-80. PubMed ID: 8643087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in rapid desensitization of 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptor-mediated phospholipase C activation.
    Berg KA; Stout BD; Maayani S; Clarke WP
    J Pharmacol Exp Ther; 2001 Nov; 299(2):593-602. PubMed ID: 11602671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substituted hexahydrobenzodipyrans as 5-HT2A/2C receptor probes.
    Whiteside MS; Kurrasch-Orbaugh D; Marona-Lewicka D; Nichols DE; Monte A
    Bioorg Med Chem; 2002 Oct; 10(10):3301-6. PubMed ID: 12150876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agonist high and low affinity state ratios predict drug intrinsic activity and a revised ternary complex mechanism at serotonin 5-HT(2A) and 5-HT(2C) receptors.
    Egan C; Grinde E; Dupre A; Roth BL; Hake M; Teitler M; Herrick-Davis K
    Synapse; 2000 Feb; 35(2):144-50. PubMed ID: 10611640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: evidence for agonist-directed trafficking of receptor stimulus.
    Berg KA; Maayani S; Goldfarb J; Scaramellini C; Leff P; Clarke WP
    Mol Pharmacol; 1998 Jul; 54(1):94-104. PubMed ID: 9658194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterisation of human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors expressed in the human neuroblastoma cell line SH-SY5Y: comparative stimulation by hallucinogenic drugs.
    Newton RA; Phipps SL; Flanigan TP; Newberry NR; Carey JE; Kumar C; McDonald B; Chen C; Elliott JM
    J Neurochem; 1996 Dec; 67(6):2521-31. PubMed ID: 8931486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular pharmacology and ligand docking studies reveal a single amino acid difference between mouse and human serotonin 5-HT2A receptors that impacts behavioral translation of novel 4-phenyl-2-dimethylaminotetralin ligands.
    Canal CE; Cordova-Sintjago T; Liu Y; Kim MS; Morgan D; Booth RG
    J Pharmacol Exp Ther; 2013 Dec; 347(3):705-16. PubMed ID: 24080681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different regulation of rat 5-HT(2A) and rat 5-HT(2C) receptors in NIH 3T3 cells upon exposure to 5-HT and pipamperone.
    Oekelen DV; Jurzak M; Van de Wiel D; Van Hecke G; Luyten WH; Leysen JE
    Eur J Pharmacol; 2001 Aug; 425(1):21-32. PubMed ID: 11672571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activating mutations of the serotonin 5-HT2C receptor.
    Herrick-Davis K; Egan C; Teitler M
    J Neurochem; 1997 Sep; 69(3):1138-44. PubMed ID: 9282936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A unique phenotype of 5-HT2C, agonist-induced GTPgamma35S binding, transferable to 5-HT2A and 5-HT2B, upon swapping intracellular regions.
    Alberts GL; Chio CL; Im WB; Slightom JL
    Br J Pharmacol; 2003 Feb; 138(3):427-34. PubMed ID: 12569067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.